Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SGMO
SGMO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SGMO News
Sangamo Therapeutics Secures Over $130 Million in Funding and FDA Fast Track Designation
13h ago
Yahoo Finance
Sangamo Therapeutics Q4 2025 Earnings Call Insights
17h ago
seekingalpha
Sangamo Therapeutics Reports Q4 Loss and Revenue Miss
20h ago
seekingalpha
Multiple Companies Set to Report Earnings
21h ago
NASDAQ.COM
Major Earnings Reports Expected After Monday's Close
1d ago
seekingalpha
Sangamo Advances Gene Therapy Application for Fabry Disease
Mar 09 2026
Newsfilter
Sangamo Reports Positive Data for Fabry Disease Treatment
Feb 04 2026
NASDAQ.COM
Sangamo Therapeutics Shares Plunge Over 31%
Feb 03 2026
Yahoo Finance
Sangamo Therapeutics Shares Plunge 28% After $25M Stock Offering
Feb 03 2026
seekingalpha
Sangamo Therapeutics Announces Pricing of Stock Offering
Feb 03 2026
Newsfilter
Sangamo Initiates BLA Submission for ST-920, Expected in Q2 2026
Dec 18 2025
Globenewswire
Sangamo Initiates BLA Submission for ST-920, Expected Completion in Q2 2026
Dec 18 2025
Newsfilter
Sangamo Receives FDA Fast Track Designation for ST-503 in Chronic Pain Treatment
Dec 02 2025
Globenewswire
Sangamo Soars After FDA Awards Fast Track Designation to Neuropathic Pain Treatment
Dec 02 2025
SeekingAlpha
Sangamo Receives FDA Acceptance for Gene Therapy BLA Submission
Nov 24 2025
Newsfilter
FDA Approves Sangamo's Proposal for Rolling BLA Submission of Gene Therapy Candidate for Fabry Disease
Nov 21 2025
NASDAQ.COM
Show More News
